Breakthroughs
FDA Approves First mRNA Flu Vaccine: What Older Adults Need to Know for the 2026-27 Flu Season
The U.S. Food and Drug Administration (FDA) has approved mFLUSIVA, the first mRNA-based influenza vaccine, for adults aged 50 and older — just in time...